#

Investment ideas

: 783
Apple, NYT, Chevron: what Berkshire bought and sold in Buffetts last quarter
News·
Apple, NYT, Chevron: what Berkshire bought and sold in Buffett's last quarter
JPMorgan believes that the shares of a number of companies have been overly affected by the sell-off driven by fears about AI / Photo: Shutterstock.com/4kclips
News·
JPMorgan picks "undervalued" stocks for which AI is not a threat
Analysts see strong upside potential in these three small-cap stocks / Photo: Facebook / Parpointofsale
Small Caps·
TipRanks flags three 'strong buy' small caps with 95% upside in 2026
Difficult periods for quality stocks have historically been an indicator of future positive momentum, notes JPMorgan Chase / Photo: lentamart / Shutterstock.com
News·
'A once-in-a-generation chance'. Why JPMorgan advises to buy unpopular quality stocks
Freedom is opening a short-term trade idea on the small aluminum producer Century / Photo: Century Aluminum
Small Caps·
Freedom short-term trade idea: Buy Century Aluminum as beneficiary of Trump policies
Goldman Sachs names stocks resilient to the AI threat / Photo: DennisF / Shutterstock.com
News·
Goldman offered stocks to protect against the "soft-apocalypse." They are growing faster than the S&P 500
Citi upgraded Ferraris stock rating for the first time in two years / Photo: X/ScuderiaFerrari
News·
Ferrari got rid of its latest recommendation to sell shares. What's their potential?
Jefferies sees potential for Beta’s stock to rise 55% / Photo: Facebook / BetaElectricAviation
Small Caps·
Mid-cap electric airplane maker Beta soars 16% as Jefferies upgrades to 'buy'
Goldman Sachs recommended buying shares of uranium company Energy Fuels / Photo: LinkedIn / Energy Fuels Resources
Small Caps·
'Uniquely positioned': Goldman initiates on uranium company Energy Fuels with 'buy'
Relmadas dual focus on cancer and CNS disease drugs has attracted investors, according to Freedom analysts / Photo: Shutterstock.com
Small Caps·
Why Wall Street still sees upside in biotech Relmada after 800% growth in 2025
A Motley Fool analyst says Viking is the under-the-radar GLP-1 contender that growth hunters cant ignore / Photo: Facebook / Nasdaq
Small Caps·
Motley Fool calls Viking the GLP‑1 drugmaker growth-hunting investors 'can't ignore'
UBS urged investors to analyze the concentration of software developer stocks in their portfolios / Photo: Michael Derrer Fuchs / Shutterstock.com
News·
UBS downgraded the U.S. technology sector. Sell or buy shares?
Load more